Orally administrable formulations of quinolone- or naphthyridone

Details Orally administrable formulations of quinolone- or naphthyridone Orally administrable formulations of quinolone- or naphthyridone

1996-12-06

1998-09-15

Dentz, Bernard

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

546123, 514312, 514300, C07D21516, A61K 3147

Patent

active

058080767

ABSTRACT:
The present invention relates to the preparation of orally administrable formulations of quinolone- or naphthyridonecarboxylic acids by mixing quinolone- or naphthyridonecarboxylic acids as such or in the form of their water-soluble salts or derivatives, preferably in the form of their aqueous salt solutions, with embonic acid as such or in the form of its water-soluble salts or derivatives, preferably in the form of its aqueous salt solutions, in the presence of an excipient, optionally in the presence of auxiliaries, when using dry mixtures in the presence of water, and optionally converting the mixture obtained into further ready-to-use forms.

REFERENCES:
patent: 5202337 (1993-04-01), Peterson et al.
patent: 5281596 (1994-01-01), Kitao et al.

Affiliated with

Also associated with

Rating

Orally administrable formulations of quinolone- or naphthyridone does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Orally administrable formulations of quinolone- or naphthyridone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Orally administrable formulations of quinolone- or naphthyridone will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-89352